The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials by Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos

Get full text

Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing? by Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Alex Al Khoury, Talat Bessissow, Peter Laszlo Lakatos

Get full text

Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis by Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Dirlene Melo Santa Maria, Usiara Britto, Gary Edward Wild, Waqqas Afif, Alain Bitton, Talat Bessissow, Peter Laszlo Lakatos

Get full text

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity? by Maria Papp, Gary L Norman, Zsuzsanna Vitalis, Istvan Tornai, Istvan Altorjay, Ildiko Foldi, Miklos Udvardy, Zakera Shums, Tamas Dinya, Peter Orosz, Bela Lombay, Gabriella Par, Alajos Par, Gabor Veres, Timea Csak, Janos Osztovits, Ferenc Szalay, Peter Laszlo Lakatos

Get full text